The present findings unravel novel mechanisms involved in Shh signaling modulation, thus offering further insights with therapeutic relevance in neurodegenerative diseases, including ALS therapy, which is currently based on glutamate toxicity and oxidative stress and is incapable of preventing progression of such a complex disease [39,40,41]. The gene discussed is SHH; the disease is neurodegenerative disease.